Zymeworks ZYME
NASDAQ ZYME
$29.99 -1.47 (-4.67%)
As of: Nov 11, 2026 · 11:46 AM EST

Zymeworks (ZYME) EBIT Margin (2021 - 2026)

Updated

Zymeworks' EBIT Margin came in at -918.95% for Q2 2026, down 917.57 percentage points from -1.38% a year earlier but up 1037.77 percentage points from the prior quarter.

Analysis

Zymeworks (ZYME) EBIT Margin (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Zymeworks reported EBIT Margin of -418.99%, down 351.68 percentage points year-over-year; for FY2025, it came in at -87.34%, up 92.35 percentage points from FY2024.

  • EBIT Margin carries a five-year change of +393.95 percentage points (FY2020 to FY2025).
  • Going back by year, EBIT Margin was -179.69% in FY2024 (+1.93 pp), -181.62% in FY2023 (-213.26 pp), 31.64% in FY2022 (+839.86 pp) and -808.22% in FY2021 (-326.93 pp).
  • The five-year range for quarterly EBIT Margin is -3793.63% (Q1 2022) to 79.35% (Q4 2022).
  • Year-over-year, EBIT Margin has declined for three consecutive quarters, with an average year-over-year change of -471.48 percentage points over the last eight quarters.
  • The fastest year-over-year change in EBIT Margin over five years came in Q1 2023 (a gain of 3716.95 percentage points), and the weakest in Q1 2026 (a drop of 1862.25 percentage points).
  • Business Quant data shows ZYME's EBIT Margin at -1956.73% (Q1 2026), -1755.55% (Q4 2025) and -80.07% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Zymeworks 2.24 Bn 1.27 Bn - 69.25%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 69.25%
Jun 30, 2026 -918.95%
Mar 31, 2026 -1,956.73%
Dec 31, 2025 -1,755.55%
Sep 30, 2025 -80.07%
Jun 30, 2025 -1.38%
Mar 31, 2025 -94.48%
Dec 31, 2024 -71.60%
Sep 30, 2024 -213.78%
Jun 30, 2024 -222.87%
Mar 31, 2024 -376.89%
Dec 31, 2023 -138.37%
Sep 30, 2023 -201.36%
Jun 30, 2023 -772.84%
Mar 31, 2023 -76.68%
Dec 31, 2022 79.35%
Sep 30, 2022 -1,914.03%
Jun 30, 2022 -1,209.54%
Mar 31, 2022 -3,793.63%
Dec 31, 2021 -205.58%
API Access

Zymeworks EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZYME&period=max&api_key=YOUR_API_KEY